跳至主要内容
临床试验/NCT01097980
NCT01097980已完成不适用

The Efficacy of Trazodone for Selective Serotonin Reuptake Inhibitor-induced Sexual Dysfunction

Beitou Armed Forces Hospital, Taipei, Taiwan1 个研究点 分布在 1 个国家目标入组 56 人开始时间: 2010年4月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
56
试验地点
1
主要终点
The differences between trazodone and placebo in the Arizona Sexual Experiences Scale-Chinese Version scale at the end of week 6 were used as the primary study outcomes.

研究概览

简要总结

The aim of this study is to investigate the efficacy of trazodone in the treatment of selective serotonin reuptake inhibitor(s) associated sexual dysfunction. The secondary domains assessed were the relationship between 5-HT2A polymorphism and treatment efficacy.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Single Group
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
20 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

研究组 & 干预措施

Trazodone

Experimental

Trazodone versus placebo in a randomized, double-blind manner

干预措施: Trazodone (Drug)

Placebo

Placebo Comparator

Patients received placebo

干预措施: Placebo (Drug)

结局指标

主要结局

The differences between trazodone and placebo in the Arizona Sexual Experiences Scale-Chinese Version scale at the end of week 6 were used as the primary study outcomes.

时间窗: week 0 and week 6

次要结局

  • The association between 5-HT2A polymorphism and the changes in Arizona Sexual Experiences Scale-Chinese Version scale were evaluated.(week 6)

研究者

发起方
Beitou Armed Forces Hospital, Taipei, Taiwan
申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

Kuo-Tung Chiang

Department of Psychiatry

Beitou Armed Forces Hospital, Taipei, Taiwan

研究点 (1)

Loading locations...

相似试验